Devonian Health Group Inc Market Cap ($15.09 Million)
Market Cap & Net Worth: Devonian Health Group Inc (GSD)
Devonian Health Group Inc market cap. Devonian Health Group Inc (V:GSD) has a market capitalization of $15.09 Million (CA$20.86 Million) as of November 1, 2026. Listed on the V stock exchange, this Canada-based company holds position #25831 globally and #1018 in its home market, demonstrating a -6.25% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Devonian Health Group Inc's stock price CA$7.50 by its total outstanding shares 2780866 (2.78 Million). Also see cash flow conversion of Devonian Health Group Inc for how efficiently the company converts equity into cash flow.
Devonian Health Group Inc Market Cap History (2015–2026)
Devonian Health Group Inc market cap history from 2015 to 2026. Data shows growth from $321.86K to $15.09 Million (41.71% CAGR). Check today's stock price for Devonian Health Group Inc for real-time trading data and today's change.
Devonian Health Group Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Devonian Health Group Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Devonian Health Group Inc (GSD) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.02x
Devonian Health Group Inc's market cap is 0.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $633.67K | $3.20 Million | -$3.19 Million | 0.20x | N/A |
| 2019 | $331.92K | $5.94 Million | -$2.98 Million | 0.06x | N/A |
| 2020 | $261.51K | $2.14 Million | -$4.37 Million | 0.12x | N/A |
| 2021 | $1.17 Million | $1.47 Million | -$3.35 Million | 0.79x | N/A |
| 2022 | $683.96K | $2.31 Million | -$3.45 Million | 0.30x | N/A |
| 2023 | $291.69K | $2.35 Million | -$4.60 Million | 0.12x | N/A |
| 2024 | $321.86K | $19.31 Million | -$1.83 Million | 0.02x | N/A |
| 2025 | $382.21K | $23.59 Million | -$6.01 Million | 0.02x | N/A |
Competitor Companies of GSD by Market Capitalization
Companies near Devonian Health Group Inc in the global market cap rankings as of November 1, 2026. Also see GSD total assets for a full breakdown of the balance sheet.
Key companies related to Devonian Health Group Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #182 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #371 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #412 globally with a market cap of $68.91 Billion USD ( AU$97.38 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #495 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #182 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $558.88 |
| #371 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $927.89 |
| #412 | CSL Ltd | AU:CSL | $68.91 Billion | AU$200.73 |
| #495 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $221.72 |
Market Capitalization of Devonian Health Group Inc (2015–2026)
Market capitalization of Devonian Health Group Inc from 2015 to today. Between 2015 and today, Devonian Health Group Inc's market cap moved from $321.86K to $ 15.09 Million, with a yearly change of 41.71%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$15.09 Million | +3847.37% |
| 2025 | CA$382.21K | +18.75% |
| 2024 | CA$321.86K | +10.34% |
| 2023 | CA$291.69K | -57.35% |
| 2022 | CA$683.96K | -41.38% |
| 2021 | CA$1.17 Million | +346.15% |
| 2020 | CA$261.51K | -21.21% |
| 2019 | CA$331.92K | -47.62% |
| 2018 | CA$633.67K | -42.73% |
| 2017 | CA$1.11 Million | +243.75% |
| 2016 | CA$321.86K | 0.00% |
| 2015 | CA$321.86K | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Devonian Health Group Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $15.09 Million USD |
| MoneyControl | $15.09 Million USD |
| MarketWatch | $15.09 Million USD |
| marketcap.company | $15.09 Million USD |
| Reuters | $15.09 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Devonian Health Group Inc
Devonian Health Group Inc. operates as a clinical stage biopharmaceutical corporation with novel therapeutic approaches targeting unmet medical needs in Canada and Internationally. It engages in the development of botanical drugs. Its lead product candidate is Thykamine that is in phase 3 clinical trial for the treatment of Atopic dermatitis in adult population; in phase 2/3 clinical trial for At… Read more